Search Within

Immunology Program Faculty

  1. "2022"
Formats
  1. Journal Article (47)
  2. Meeting Abstract (26)
  3. Review (3)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. GSK Faculty (79)
  2. Sloan Kettering Institute Faculty (79)
  3. Department of Medicine (55)
  4. Sloan Kettering Institute Postdocs (51)
  5. Center for Hematologic Malignancies (42)
  6. Hematologic Malignancies, Division of (36)

More Groups

People
  1. Marcel Van Den Brink (29)
  2. Sergio Giralt (16)
  3. Jonathan Peled (15)
  4. Miguel-Angel Perales (13)
  5. Richard O'Reilly (13)
  6. Michael Scordo (10)

More People

Years
  1. 2022 (79)
Publications
  1. Blood (13)
  2. Cancer Research (5)
  3. Immunity (4)
  4. Journal of Clinical Oncology (4)
  5. Blood Advances (3)
  6. Journal of Experimental Medicine (3)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (13)
  3. American Association for Cancer Research (8)
  4. Elsevier Inc. (6)
  5. American Society of Clinical Oncology (4)
  6. Cell Press (4)

More Publishers

Results (79)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Epigenetic control of tumor cell killing by natural killer cells
    Meeting Abstract

    Pasion, J.; Barisic, D.; Meydan, C.; Ng, K. Y.; Lafoz, M. T.; Huse, M.; Melnick, A.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
    Meeting Abstract

    George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Acute kidney injury induced by allogeneic hematopoietic stem cell transplantation: disease understanding and treatment with nanotechnology-based therapeutics
    Meeting Abstract

    Panagiotakopoulou, M.; Grabarnik, E.; Jaimes, E. A.; van den Brink, M. R.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Microbial changes in response to a plant-based diet and/or supplements in SMM patients: A national multi-arm randomized prospective telehealth study via HealthTree: The nutrition prevention (NUTRIVENTION-2) study
    Meeting Abstract

    Castro, F.; Sweeney, N. W.; Derkach, A.; Traore, K.; Anuraj, A.; Guttentag, L.; Blaslov, J.; Sahagun, A.; Hydren, J.; Chmielewski, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Ponce, D. M.; Peled, J. U.; Tejura, B.; Ford, C.; van den Brink, M. R. M.; Lombardo, M. J.; Kosuri, S.; Khera, N.; Defilipp, Z.; von Moltke, L.
    Blood (2022)

    Fulltext@MSK | Save
  • Precision targeting of MYD88 mutant DLBCL using the novel combination of irakimids and BCL2 inhibition
    Meeting Abstract

    Grilo, A. M.; Klaus, C.; McDonald, A.; Gollob, J.; Weiss, M.; O'Connor, O. A.; Salles, G.; Chaudhuri, J.; Lue, J. K.
    Blood (2022)

    Fulltext@MSK | Save
  • Updated efficacy and safety of tabelecleucel in patients with Epstein-Barr virus-positive (EBV(+)) leiomyosarcomas (LMS)
    Meeting Abstract

    Jimenez-Kurlander, L. S.; Behr, G.; Bunin, N. J.; Doubrovina, E.; Dinavahi, R.; Gamelin, L.; Ghobadi, A.; Mascarenhas, L.; Nikiforow, S.; O'Reilly, R. J.; more...
    Blood (2022)

    Fulltext@MSK | Save